Insider Transactions
| Date | Name | Title | Type | Shares Traded | Price Range |
|---|---|---|---|---|---|
| Feb 17, 2021 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,000 | $3.61 |
| Feb 10, 2021 |
Chief Legal Officer
|
Chief Legal Officer | Open market or private sale of non-derivative or derivative security | 2,500 | $3.93 |
| Feb 10, 2021 |
Chief Legal Officer
|
Chief Legal Officer | Other acquisition or disposition | -- | -- |
| Feb 09, 2021 |
Chief Legal Officer
|
Chief Legal Officer | Open market or private sale of non-derivative or derivative security | 1,977 | $3.93 |
| Jan 20, 2021 |
EVP & Chief Financial Officer
|
EVP & Chief Financial Officer | Open market or private sale of non-derivative or derivative security | 1,944 | $4.31 |
| Jan 20, 2021 |
EVP & Chief Financial Officer
|
EVP & Chief Financial Officer | Other acquisition or disposition | -- | -- |
| Jan 20, 2021 |
EVP, COO & CCO
|
EVP, COO & CCO | Open market or private sale of non-derivative or derivative security | 10,000 | $4.31 |
| Jan 20, 2021 |
EVP, COO & CCO
|
EVP, COO & CCO | Other acquisition or disposition | -- | -- |
| Jan 20, 2021 |
Director, CEO & President
|
Director, CEO & President | Open market or private sale of non-derivative or derivative security | 3,889 | $4.31 |
| Jan 20, 2021 |
Director, CEO & President
|
Director, CEO & President | Other acquisition or disposition | -- | -- |
| Jan 19, 2021 |
EVP & Chief Financial Officer
|
EVP & Chief Financial Officer | Open market or private sale of non-derivative or derivative security | 2,582 | $3.81 |
| Jan 19, 2021 |
EVP, COO & CCO
|
EVP, COO & CCO | Open market or private sale of non-derivative or derivative security | 64,626 | $4.00 |
| Jan 19, 2021 |
EVP, COO & CCO
|
EVP, COO & CCO | Open market or private sale of non-derivative or derivative security | 11,657 | $3.81 |
| Jan 19, 2021 |
Director, CEO & President
|
Director, CEO & President | Open market or private sale of non-derivative or derivative security | 3,844 | $3.81 |
| Dec 24, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,000 | $3.79 |
| Dec 18, 2020 |
Director, CEO & President
|
Director, CEO & President | Other acquisition or disposition | -- | -- |
| Dec 16, 2020 |
EVP & Chief Financial Officer
|
EVP & Chief Financial Officer | Other acquisition or disposition | -- | -- |
| Dec 16, 2020 |
Director, CEO & President
|
Director, CEO & President | Open market or private sale of non-derivative or derivative security | 150,899 | $4.70 |
| Dec 14, 2020 |
EVP & Chief Financial Officer
|
EVP & Chief Financial Officer | Open market or private sale of non-derivative or derivative security | 25,696 | $5.00 |
| Dec 10, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- |
| Dec 10, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- |
| Nov 20, 2020 |
Director, CEO & President
|
Director, CEO & President | Other acquisition or disposition | -- | -- |
| Nov 18, 2020 |
Director, CEO & President
|
Director, CEO & President | Open market or private sale of non-derivative or derivative security | 162,473 | $4.13 |
| Nov 09, 2020 |
Chief Medical Officer
|
Chief Medical Officer | Open market or private sale of non-derivative or derivative security | 5,000 | $3.56 |
| Nov 09, 2020 |
Chief Medical Officer
|
Chief Medical Officer | Other acquisition or disposition | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.